The Tikhoff-Linberg Procedure: A Comprehensive Clinical Guide

1. Comprehensive Introduction & Overview

The Tikhoff-Linberg procedure, often referred to as a shoulder-girdle resection or interscapulothoracic resection, represents one of the most radical and technically demanding orthopedic oncological interventions. First described independently by Vladimir Tikhoff and Boris Linberg in the early 20th century, this limb-salvage procedure is designed to excise primary malignant tumors of the shoulder girdle while preserving the distal extremity (the arm, forearm, and hand).

Unlike an interscapulothoracic amputation (forequarter amputation), which requires the removal of the entire upper extremity, the Tikhoff-Linberg procedure preserves neurovascular continuity, allowing the patient to retain a functional, albeit weakened, hand and forearm. This procedure is a cornerstone in the management of high-grade sarcomas located in the proximal humerus, scapula, or clavicle, where wide surgical margins are essential for oncological control, but where the distal neurovascular bundle remains uninvolved.

2. Deep-Dive: Technical Specifications and Mechanisms

The fundamental mechanism of the Tikhoff-Linberg procedure is the en-bloc resection of the scapula, the lateral two-thirds of the clavicle, and the proximal humerus. The procedure relies on the anatomical principle that the brachial plexus and the axillary artery/vein can be dissected free from the tumor mass and retracted, allowing for the removal of the bone-tumor complex while maintaining distal perfusion and innervation.

The Anatomical Triad of Resection

The procedure mandates the excision of three primary skeletal components:
1. The Scapula: The entire scapula is removed, including the glenoid fossa.
2. The Proximal Humerus: The extent of the humeral resection is determined by the tumor's distal margin, usually requiring an osteotomy at the mid-diaphysis.
3. The Lateral Clavicle: The clavicle is divided to allow for the mobilization of the shoulder girdle and access to the subclavian/axillary vessels.

Surgical Mechanism

The preservation of function is achieved through meticulous dissection. The surgeon must navigate the "space" between the tumor and the neurovascular bundle. The distal arm is effectively "suspended" by the preserved musculature (such as the latissimus dorsi and pectoralis major, if not compromised by the tumor) and the neurovascular bridge.

3. Extensive Clinical Indications & Usage

The Tikhoff-Linberg procedure is not a first-line treatment for common orthopedic conditions. It is strictly reserved for complex oncological cases.

Primary Indications

• High-Grade Sarcomas: Chondrosarcoma, osteosarcoma, or Ewing’s sarcoma located in the scapula or proximal humerus.
• Soft Tissue Sarcomas: Large, deep-seated tumors (e.g., undifferentiated pleomorphic sarcoma) involving the shoulder girdle musculature.
• Recurrent Tumors: Cases where prior radiotherapy or surgery has failed, provided distal neurovascular structures are spared.
• Metastatic Disease: In rare instances, for solitary, painful, or pathological fractures of the shoulder girdle that do not respond to palliative radiotherapy.

Pre-operative Preparation

1. Multidisciplinary Tumor Board Review: Essential for verifying the necessity of such an aggressive procedure.
2. Advanced Imaging: MRI with contrast is the gold standard for evaluating the proximity of the tumor to the brachial plexus and axillary vessels. CT angiography is frequently utilized to map the vascular supply.
3. Neoadjuvant Therapy: Most patients undergo chemotherapy or radiotherapy to shrink the tumor, facilitating a safer "wide margin" resection.
4. Psychological Evaluation: Patients must understand the significant shift in shoulder mechanics and the prolonged rehabilitation required.

4. Steps of the Surgical Intervention

The procedure is highly complex and typically performed by a team of orthopedic oncologists and vascular surgeons.

1. Positioning: The patient is placed in a lateral decubitus or semi-lateral position.
2. Incision: A large "S" or "T" shaped incision is made over the shoulder, extending from the clavicle to the axilla and down the arm.
3. Vascular/Nerve Mobilization: The brachial plexus and axillary vessels are carefully isolated. This is the most critical step; any damage here results in a flail or ischemic limb.
4. Osteotomy:
   • The clavicle is osteotomized.
   • The proximal humerus is transected at a pre-determined level.
   • The scapula is detached from the thoracic wall by dividing the muscles (trapezius, rhomboids, levator scapulae).
5. En-bloc Removal: The entire mass, including the tumor, is removed.
6. Reconstruction (Optional): Some surgeons attempt to reconstruct the shoulder using an allograft or a custom prosthesis, though many opt for a "Tikhoff-Linberg arthroplasty" where the humerus is fused to the chest wall or simply left to form a pseudoarthrosis.
7. Closure: Meticulous closure of the remaining soft tissues to ensure coverage of the neurovascular bundle.

5. Post-operative Recovery and Outcomes

The Recovery Protocol

• Phase 1 (0–6 weeks): Protection of the neurovascular bundle. The arm is supported in a sling or orthosis to prevent traction injury to the brachial plexus.
• Phase 2 (6–12 weeks): Gentle mobilization of the elbow, wrist, and hand. Passive range of motion begins.
• Phase 3 (3 months+): Progressive strengthening. Focus on regaining functional grip strength.

Typical Outcomes

• Oncological: Generally good local control if margins are negative.
• Functional: The patient will have no active shoulder motion. However, they typically retain elbow flexion/extension and hand grip. The arm is often used as a "helper" limb.
• Cosmetic: Significant asymmetry in the shoulder area is expected.

6. Risks, Side Effects, and Contraindications

Risks and Complications

• Neurological Injury: The most feared complication. Transient or permanent brachial plexus palsy.
• Vascular Insufficiency: Risk of thrombosis or hemorrhage requiring vascular repair.
• Wound Healing Issues: Due to the large dead space and prior radiotherapy, flap necrosis is a significant risk.
• Local Recurrence: If tumor margins are "close" or "positive," recurrence rates increase significantly.
• Chronic Pain: Neuropathic pain in the distal extremity is common.

Contraindications

• Vascular Involvement: If the tumor encases the axillary artery, a forequarter amputation is usually mandatory.
• Brachial Plexus Involvement: If the tumor involves the roots of the brachial plexus, the procedure is contraindicated.
• Poor General Health: Severe comorbidities that preclude a major, long-duration surgery.

7. Alternative Treatments

8. Massive FAQ Section

1. Is the Tikhoff-Linberg procedure considered an amputation?
No. It is a resection. An amputation implies the removal of the limb. The Tikhoff-Linberg procedure preserves the distal extremity (the arm, forearm, and hand).

2. Will I have a shoulder joint after the surgery?
No. The glenoid fossa and proximal humerus are removed. You will not have a functional shoulder joint, and the arm will be connected to the body primarily through soft tissues.

3. What is the most common indication for this procedure?
High-grade malignant bone tumors (sarcomas) of the scapula or proximal humerus that are too large for simple resection but do not involve the brachial plexus.

4. How long does the surgery take?
It is a major procedure, often lasting between 6 to 10 hours depending on the complexity of the tumor and the need for vascular reconstruction.

5. Will I have feeling in my hand after the surgery?
Yes, provided the brachial plexus is safely preserved during the dissection. However, some patients experience temporary numbness or tingling post-operatively.

6. What is the biggest risk of the procedure?
Damage to the brachial plexus or the axillary artery, which could lead to loss of function or perfusion in the preserved distal limb.

7. Can the shoulder be reconstructed?
While some surgeons use custom implants or bone grafts, the "Tikhoff-Linberg" is typically defined by the lack of a formal, high-functioning shoulder replacement. Most patients rely on a pseudoarthrosis.

8. What is the recovery time?
Full recovery of hand and elbow function can take 6 to 12 months of intensive physical therapy.

9. Is this procedure performed often?
No, it is a rare, specialized procedure performed only at major orthopedic oncology centers by highly experienced surgeons.

10. What happens if the tumor comes back?
Local recurrence is a significant challenge. Depending on the extent, further surgery (often an amputation) or palliative radiotherapy may be required.

9. Conclusion

The Tikhoff-Linberg procedure remains one of the most remarkable feats of orthopedic surgery. By prioritizing the preservation of the distal extremity, it offers a functional alternative to the life-altering consequences of a forequarter amputation. While the procedure carries substantial risks and requires a grueling recovery, for the right patient, it provides the best balance between aggressive oncological resection and the preservation of quality of life. Surgeons must maintain a rigorous focus on anatomical precision, and patients must be supported by a dedicated multidisciplinary team throughout their journey to recovery.